Ascendis Pharma A/S (ASND) vs Summit Therapeutics PLC (SMMT)

Ascendis Pharma A/S and Summit Therapeutics PLC are both Biotechnology companies. Ascendis Pharma A/S is the larger, with a market value of $15.7B against $13.1B — 1.2× the size. Summit Therapeutics PLC has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 16.3×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against −61.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs 0.00%) and the higher return on invested capital (15.1% vs 0.00%). Across the 18 metrics below, Ascendis Pharma A/S leads on 15 and Summit Therapeutics PLC on 3.